Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells
Elisabeth Mack(Universitätsklinikum Gießen und Marburg), Jörg Hoffmann(Philipps University of Marburg), Andreas Neubauer(RWTH Aachen University), Christoph Mann(Universitätsklinikum Gießen und Marburg), Ellen Wollmer(Philipps University of Marburg), Sören Hartmann(Universitätsklinikum Gießen und Marburg), Petra Ross(Universitätsklinikum Gießen und Marburg), Cornelia Brendel(Philipps University of Marburg)
Cited by 24
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)
|Journal of Clinical Oncology|2005|573